Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats

Polish Journal of Pharmacology

Volumn 54, Issue 5, 2002, Pages 469-473

  Azzadin, Arsalan ^a   Małyszko, Jolanta ^a   Małyszko, Jacek S ^a   Tankiewicz, Anna ^a   Myśliwiec, Michał ^a   Buczko, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cyclosporine; Enalapril; Losartan; Uremia

Indexed keywords

CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; UREA; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFECT; HEMATOCRIT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; NONHUMAN; RAT; RENOVASCULAR HYPERTENSION; UREA BLOOD LEVEL; UREMIA; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; KIDNEY; PATHOPHYSIOLOGY; WISTAR RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CREATININE; CYCLOSPORINE; ENALAPRIL; HEMATOCRIT; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LOSARTAN; MALE; RATS; RATS, WISTAR; UREA; UREMIA;

EID: 0036401237     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Boran M., Gonenc F., Cetin S.: Losartan in renal allograft recipients receiving cyclosporine A. Nephron, 1999, 83, 93-94.
2. Borel J.F., Feurer C., Magnee C., Stahelin H.: Effects of the new antilymphocytic peptide cyclosporine A in animals. Immunology, 1977, 32, 1017-1025.
3. Brox A.G., Mangel J., Hanley J.A., Louis G.St., Mongrain S., Gagnon R.F.: Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins. Transplantation, 1998, 66, 1053-1058.
4. Douglas J.G.: The curtain rises on the renin-angiotensin system: AT2 receptors are in the spotlight. J. Clin. Invest., 1996, 97, 1787.
5. Goodfriend T.L., Elliott M.E., Catt K.J.: Angiotensin receptors and their antagonist. N. Engl. J. Med., 1996, 334, 1649-1654.
6. Lassila M., Finckenberg P., Pere A.K., Krogerus L., Ahonen J., Vapaatalo H., Nurminen M.L.: Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. Brit. J. Pharmacol., 2000, 130, 1339-1347.
7. Martinez-Castelao A., Hueso M., Sanz V., Rejas J., Alsina J., Grinyo J.M.: Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin. Kidney Int., 1998, 68, Suppl., S130-S134.
8. Mason J.: Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol. Rev., 1989, 42, 423-434.
9. Matsukawa T., Ichikawa I.: Biological functions of angiotensin and its receptors. Ann. Rev. Physiol., 1997, 59, 395-412.
10. Mervaala E., Lassila M., Vaskonen T., Krogerus L., Lahteenmaki T., Vapaatalo H., Karppanen H.: Effects of ACE inhibition on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on a high-sodium diet. Blood Press., 1999, 8, 49-56.
11. Murray B.M., Paller M.S., Ferris T.F.: Effect of CsA administration on renal hemodynamics in conscious rats. Kidney Int., 1985, 28, 767-774.
12. Pichler R.H., Franceschini N., Young B.A., Hugo C., Ando H.T.F., Burdmann E.A., Shankland S.J.: Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J. Amer. Soc. Nephrol., 1995, 4, 1186-1196.
13. Rutkowski B., Hoppe A., Manitius A.: Blood glucose and insulin levels following glucose load in rats with chronic renal failure. Acta Med. Pol., 1981, 3, 22-27.
14. Sullivan B.A., Hak L.J., Finn W.F.: Cyclosporine nephrotoxicity: studies in laboratory animals. Transplant. Proc., 1985, 17, 145-154.
15. Van der Schaaf M.R., Hene RJ., Floor M., Blankestijn P.J., Koomans H.A.: Hypertension after renal transplantation. Calcium channel or converting enzyme blockade? Hypertension, 1995, 25, 77-81.